Sponsored Links

 

Displaying glp 1 inhibitors PowerPoint Presentations



Incretin Based Therapy of Type 2 Diabetes Mellitus PPT

Presentation Summary : Summary DPP-IV inhibitors raise GLP-1 levels 2- to 3-fold. ... most people with type 1 and type 2 diabetes have accelerated gastric emptying compared to those without ...

Source : http://www.bibalex.org/diabetessupercourse/DiabetesPPTLectures/Copy%20of%20Incretin%20Based%20Therapy%20of%20Type%202%20Diabetes%20Mellitus_1.ppt

Projects In Knowledge How to Create a PowerPoint Webcast This ... PPT

Presentation Summary : Type 2 Diabetes Treatment: Novel Therapies GLP-1 Receptor Agonists/Analogs and DPP-4 Inhibitors Jaime A. Davidson, MD, FACP, MACE Clinical Professor of Medicine

Source : http://www.projectsinknowledge.com/Activity/slides/2189_1.ppt

Slide 1 PPT

Presentation Summary : Challenges in the Management of T2DM—Exploring the Role of GLP-1 Receptor Agonists: Southern Region Frank Svec, MD, PhD Clinical Professor of Medicine

Source : http://img.medscape.com/images/718/355/Diab-ArchiveRegionalCMELive-Svec-GLP-1-Slides-4a.ppt

The Pyramid of Recent Trials - Lipids Online - Educational ... PPT

Presentation Summary : DPP-4 Inhibitors vs. GLP-1 Agonists DPP-4 inhibitors GLP-1 and GIP enhanced Physiological fluctuations in hormone levels Limited by endogenous secretion Comparable ...

Source : http://lipidsonline.org/ppt_dir/source_ppts/93.ppt

Effect of Glucagon-Like Peptide-I (GLP-I) Analogue in ... PPT

Presentation Summary : GLP-1 and Exenatide Exenatide is a synthetic analogue of ... ACE inhibitors/ARB and Beta Blockers Loop diuretics ± Spironolactone Stable coronary artery ...

Source : http://www.chsbuffalo.org/files/Medical_Education/BANDAY%20Effect%20of%20Glucagon-Like%20Peptide-I%20(GLP-I)%20Analogue.ppt

Type 2 Diabetes Management Goals - outpatient.aace.com PPT

Presentation Summary : GLP-1 receptor agonists DPP-4 inhibitors TZDs Insulin (basal ... Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53. Stenlof K, et al. Diabetes Obes Metab ...

Source : http://outpatient.aace.com/sites/all/files/T2DM_S5_Treatment_041813.ppt

PowerPoint Presentation PPT

Presentation Summary : ... native GLP-1 has limited ... which is a recombinant version of the koagulation factor 7a originally developed for treating haemophilia patients with inhibitors ...

Source : http://www.novonordisk.com/images/investors/investor_presentations/2005/SG%20Cowen%20CKA03082005.ppt

GIP, GLP, and GI: New insights into type 2 DM PPT

Presentation Summary : Title: GIP, GLP, and GI: New insights into type 2 DM Author: THR USER Last modified by: Mark Feldman Created Date: 9/28/2004 3:24:20 PM Document presentation format

Source : http://phdres.caregate.net/curriculum/ppt_files/Incretins_glucose_intolerance.ppt

The Role of SGLT-2 Inhibitors in the Management of Patients ... PPT

Presentation Summary : The Role of SGLT-2 Inhibitors in the Management of Patients with Type 2 Diabetes Lawrence Blonde, MD Director, Ochsner Diabetes Clinical Research Unit,

Source : http://www.nysafp.org/images/uploads/misc/1326909268_SGLT-2%20powerpoint%20AFP.ppt

Injectable Options as Add-Ons to Basal Insulin: Targeting PPG ... PPT

Presentation Summary : Scientific Rationale for Combining Basal Insulin with a GLP-1 agonist. DPP- 4 Inhibitors as Add-ons to Basal Insulin. Pramlintide as Add-on to Basal Insulin.

Source : http://img.medscape.com/images/810/769/810769_slides.pptx

Slide 1 PPT

Presentation Summary : Sitagliptin approved Fall 2006, Vildagliptin awaiting approval. GLP-1 agonists Exenatide (Byetta) ... DPP4 inhibitors GLP-1 agonists Glitazars To sum up ...

Source : http://www.uky.edu/~hadleyr/PA2008/Palmer.ppt

Folie 1 - DiabetesPro - American Diabetes Association PPT

Presentation Summary : inhibitors. Inhibits DPP-4. Increases GLP-1, GIP. No hypoglycemia. Well tolerated. Modest A1c ? Pancreatitis. Urticaria. High. ... Folie 1 Last modified by:

Source : http://professional.diabetes.org/admin/UserFiles/0%20-%20Sean/Slide%20Decks/EASD_ADA_FINAL%20June%202012.pptx

PowerPoint Presentation PPT

Presentation Summary : GLP-1 (7-36) GLP-1 (9-36) DPP-4 DPP-4 inhibitors Biological actions ‘incretin effect’ Figure 2 GLP-1R-independent actions Saxagliptin Alogliptin Sitagliptin ...

Source : http://www.hal.inserm.fr/docs/00/65/92/69/RTF/Duez_et_al._DPP-4Inhibitors_Figures_colour.ppt

Slide 1 - Scioto County Medical Society PPT

Presentation Summary : Development of Therapeutic Agents Based on the GLP-1 Pathway Terry W. Sherraden, MD, FACE Tallahassee Endocrine Associates Tallahassee Florida Emergence of Diabetes ...

Source : http://sciotocountymedicalsociety.org/documents/Current.Therapy.GLP-1.Sherraden.ppt

Slide 1 PPT

Presentation Summary : Oral Anti-diabetic Medications Mario Skugor, MD FACE Endocrine and Metabolic Institute Cleveland Clinic Glycemic Control with GLP-1 Receptor Agonists in Head-to-Head ...

Source : http://www.osteopathic.org/inside-aoa/events/omed/omed-presentations/Documents/2013%20OMED%20Presentations/cleveland-clinic-skugor-oral-antidiabetic-medications.ppt

GLP-1 Therapy – Beyond Glucose Control - Josephine Carlos ... PPT

Presentation Summary : GLP-1 is secreted from the. L-cells of the jejunum ... Alpha-glucosidase inhibitors PPG. GI adverse effects. Insulin HbA 1c. Injectable route, hypoglycemia, weight gain.

Source : http://josephinecarlosraboca.weebly.com/uploads/5/0/2/2/5022425/incretin_aug2010.pptm

Folie 1 - Home - IMS Health PPT

Presentation Summary : European market: Biguanides and DPP IV inhibitors are primary contributors to growth, ... GLP-1 AGONISTS 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 0 0 0 0 0

Source : http://www.imshealth.com/ims/Global/EMEA/Austria%20and%20Germany/Corporate/Top-Line%20Market%20Data%20&%20Trends/Infografiken/09%20IMS_Infografik_November_Weltdiabetestag_final.pptx

Management of Type 2 Diabetes: - SouthEastern Geriatrics PPT

Presentation Summary : Glucagon-like peptide 1 (GLP-1) ... Dual-Acting Peptide for Diabetes (DAPD) GLP-1R agonist that also binds to the glucagon ... Fructose-1,6-bisphosphatase inhibitors.

Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/09/New-DMII-Treatments.pptx

Glucose homeostasis, Pathophysiology of diabetes + ADA Guidelines PPT

Presentation Summary : GLP-1 “Incretin” hormone ... to inhibit DPP-4 could sustain GLP-1 action So DPP-4 inhibitors ... 5 4 3 2 1 0 Splachnic Insulin-stimulated Glucose ...

Source : http://classof2010wiki.pbworks.com/f/Glucose+homeostasis,+Pathophys,+ADA+07.ppt

Pharmacological management Blood glucose-lowering medicines PPT

Presentation Summary : Those that slow the absorption of complex sugars and therefore slow the rise in glucose are called alpha-glucosidase inhibitors. GLP-1 (incretins) ...

Source : http://www.idf.org/sites/default/files/Module%25203.1_EN_0.pptx

No Slide Title PPT

Presentation Summary : * Slide 20 Good Glycemic Control ... Actions GLP-1 Secretion and Inactivation Inhibition of DPP-4 to Increase Active GLP-1 DPP-4 Inhibitors GLP-1 Agonists ...

Source : http://www.eatwellmd.org/docs/Annual%20Meeting%202014/Current%20Management%20of%20Type%201%20and%202%20Diabetes%20Mellitus.ppt

Sponsored Links

Report a violation: If you find a presentation that is using one of your presentation without permission, contact us immidiately at

© XPowerPoint.com